Escitalopram Sandoz

Escitalopram Sandoz





Zuellig Pharma
Concise Prescribing Info
Major depressive episodes, panic disorder w/ or w/o agoraphobia, social anxiety disorder (social phobia). Generalized anxiety disorder (GAD) & obsessive-compulsive disorder.
Dosage/Direction for Use
Major depressive episodes 10 mg once daily. Max: 20 mg once daily, after at least a wk. After symptoms resolve, treatment for at least 6 mth is required. Panic disorder w/ or w/o agoraphobia Initially 5 mg for the 1st wk before increasing to 10 mg daily. Max: 20 mg daily. Social anxiety disorder, obsessive-compulsive disorder & GAD 10 mg once daily. Max: 20 mg once daily. Elderly >65 yr Initially 5 mg once daily, may be increased to 10 mg once daily. Patients w/ mild or moderate hepatic impairment & poor metabolisers of CYP2C19 Initially 5 mg daily for the first 2 wk, may be increased to 10 mg daily.
May be taken with or without food.
Hypersensitivity. Concomitant use w/ non-selective, irreversible MAOIs; reversible MAOIs eg, moclobemide or reversible non-selective MAOIs linezolid; drugs known to prolong QT interval. Patients w/ known QT-interval prolongation or congenital long QT syndrome.
Special Precautions
Paradoxical anxiety. Discontinue if seizure occurs. Increased risk of suicide-related events. Avoid use in patients w/ unstable epilepsy. Closely monitor patients w/ controlled epilepsy. History of mania/hypomania. May alter glycaemic control. Development of akathisia or psychomotor restlessness. Patients at risk of hyponatraemia, eg, elderly & patients w/ cirrhosis; w/ known bleeding tendencies; CHD, QT interval prolongation, significant bradycardial; recent acute MI or uncompensated heart failure; angle-closure glaucoma or history of glaucoma; electroconvulsive therapy (ECT). Concomitant use w/ oral anticoagulants, drugs known to affect platelet function. Gradually taper drug when discontinuing treatment over a period of several wk or mth. Correct electrolyte disturbances eg, hypokalaemia & hypomagnesemia prior to treatment. Consider an ECG review in patients w/ stable cardiac disease. W/draw treatment if signs of cardiac arrhythmia occurs during treatment & perform ECG. May impair the ability to drive or use machinery. Pregnancy & lactation. Childn & adolescents <18 yr.
Adverse Reactions
Headache; nausea. Decreased & increased appetite, increased wt; anxiety, restlessness, abnormal dreams, decreased libido (female & male), anorgasmia (female); insomnia, somnolence, dizziness, paraesthesia, tremor; sinusitis, yawning; diarrhoea, constipation, vomiting, dry mouth; increased sweating;  arthralgia, myalgia; ejaculation disorder, impotence (male); fatigue, pyrexia.
Drug Interactions
Concomitant use w/ irreversible non-selective MAOIs & reversible, selective MAO-A inhibitor eg, moclobemide are contraindicated; reversible, non-selective MAOI eg, linezolid; irreversible, selective MAO-B inhibitor eg, selegiline; drugs that prolong QT interval eg, Class IA & III antiarrhythmics, antipsychotics (eg, phenothiazines, pimozide, haloperidol), TCAs, certain antimicrobials (eg, sparfloxacin, moxifloxacin, erythromycin IV, pentamidine, anti-malarians), certain antihistamines (eg, astemizole, mizolastine). Serotonin syndrome w/ serotonergic drugs eg, tramadol, sumatriptan & other triptans. Seizure threshold may be lowered w/ antidepressants, neuroleptics, mefloquine, bupropion & tramadol. May have enhanced effects w/ lithium & tryptophan. Increased adverse reactions w/ herbal remedies containing St. John's wort (Hypericum perforatum). May alter anti-coagulant effects of oral anticoagulants. Alcohol. Increased risk of malignant arrhythmias w/ hypokalaemia/hypomagnesaemia-inducing drugs. Moderate increased plasma conc w/ omeprazole & cimetidine. Drugs w/ narrow therapeutic index eg, flecainide, propafenone & metoprolol (when used in cardiac failure); antidepressants eg, desipramine, clomipramine or nortriptylline, antipsychotics eg, risperidone, thioridazine & haloperidol. May cause weak inhibition of drugs metabolised by CYP2C19.
MIMS Class
ATC Classification
N06AB10 - escitalopram ; Belongs to the class of selective serotonin reuptake inhibitors. Used in the management of depression.
Escitalopram Sandoz FC tab 10 mg
Escitalopram Sandoz FC tab 20 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in